Skip to main content

Plus Therapeutics Inc (PSTV) Stock

Plus Therapeutics Inc Stock Details, Movements and Public Alerts

Stock Details

Plus Therapeutics Inc (PSTV), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $0.54. Over the past 52 weeks, it has ranged between $0.16 and $2.31. This places the current price at 23.4% of its 52-week high and 237.5% above its 52-week low. Recent trading volume was recorded at 2,724,397. The 14-day Relative Strength Index (RSI) stands at 45.06, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $0.57 by 5.26%. Similarly, it is below its 200-day moving average of $0.66 by 18.18%. The MACD histogram is -0.01, indicating bearish momentum (MACD Line: -0.02, Signal Line: -0.01). There are currently 2 active alerts set for PSTV by users.

52-Week Range

$2.31 - $0.16

-76.62% from high · +237.50% from low

Avg Daily Volume

8,064,903

20-day average

100-day avg: 29,170,141

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

22.33

EV/EBITDA

-0.30

EPS (TTM)

-$1.39

Price to Sales

9.89

Beta

0.81

Less volatile than market

How is PSTV valued relative to its earnings and growth?
Valuation data is not available for this stock.
What is PSTV's risk profile compared to the market?
With a beta of 0.81, Plus Therapeutics Inc is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 22.33 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

-110.70%

EBITDA

$-12,152,000

Return on Equity

-522.00%

Return on Assets

-74.10%

Revenue Growth (YoY)

8.70%

Earnings Growth (YoY)

0.00%

How profitable and efficient is PSTV's business model?
0 The operating margin of -110.70% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -522.00% and ROA at -74.10%, the company achieves moderate returns on invested capital.
What are PSTV's recent growth trends?
Plus Therapeutics Inc's revenue grew by 8.70% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets.0 These growth metrics should be evaluated against BIOTECHNOLOGY industry averages for proper context.

Company Size & Market

Market Cap

$52.6M

Revenue (TTM)

$5.32M

Revenue/Share (TTM)

$0.33

Shares Outstanding

99.27M

Book Value/Share

$0.03

Asset Type

Common Stock

What is PSTV's market capitalization and position?
Plus Therapeutics Inc has a market capitalization of $52.6M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 99.27M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
How does PSTV's price compare to its book value?
Plus Therapeutics Inc's book value per share is $0.03, while the current stock price is $0.54, resulting in a price-to-book (P/B) ratio of 16.36. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$8.00

1381.48% upside potential

Analyst Recommendations

Strong Buy

2

Buy

2

Hold

0

Sell

0

Strong Sell

0

How reliable are analyst predictions for PSTV?
4 analysts cover PSTV with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $8.00 implies 1381.5% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on PSTV?
Current analyst recommendations:2 Strong Buy, 2 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Nov 1, 2025, 02:05 AM

Technical Indicators

RSI (14-day)

45.06

Neutral

50-Day Moving Average

$0.57

-5.26% below MA-50

200-Day Moving Average

$0.66

-18.18% below MA-200

MACD Line

-0.02

MACD Signal

-0.01

MACD Histogram

-0.01

Bearish

What does PSTV's RSI value tell investors?
The RSI (Relative Strength Index) for PSTV is currently 45.06, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
How should traders interpret PSTV's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.02 below the signal line at -0.01, with histogram at -0.01. This bearish crossover indicates downward pressure. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($0.57) is below the 200-day MA ($0.66), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Nov 10, 2025, 12:44 AM

Active Alerts

Alert Condition
Price falls below
Threshold
$0.45
Created
Nov 4, 2025, 04:36 PM
Alert Condition
RSI Threshold Cross
Threshold
35
Created
Oct 31, 2025, 04:28 PM

Stay Ahead of the Market with Plus Therapeutics Inc Alerts

Set up price alerts for Plus Therapeutics Inc and get notified instantly when the price hits your target. Never miss an important price movement again.